Skip to main content
Premium Trial:

Request an Annual Quote

BD Completes Accuri Cytometers Buy

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Becton Dickinson today announced the completion of its acquisition of Accuri Cytometers for an undisclosed amount.

Based in Ann Arbor, Mich., Accuri develops personal flow cytometers. The acquisition, announced last month during BD's first quarter earnings release, helps expand the use of flow cytometry technology in regions where ease of use and affordability are critical, BD said.

"The acquisition … complements and broadens BD's offerings for life scientists by making flow cytometry more accessible to a wider audience of scientists and clinicians," William Rhodes, president of BD Biosciences, said in a statement.

The Scan

UK Team Presents Genetic, Epigenetic Sequencing Method

Using enzymatic DNA preparation steps, researchers in Nature Biotechnology develop a strategy for sequencing DNA, along with 5-methylcytosine and 5-hydroxymethylcytosine, on existing sequencers.

DNA Biobank Developed for French Kidney Donors, Recipients

The KiT-GENIE biobank described in the European Journal of Human Genetics contains DNA samples, genotyping profiles, immune patterns, and clinical features for thousands of kidney donors or transplant recipients in Nantes, France.

Cardiometabolic Disease May Have Distinct Associations With Microbial Metabolites in Blood, Gut

By analyzing gut microbes in combination with related metabolites in feces and blood, researchers in Nature Communications found distinct cardiometabolic disease relationships at each site.

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.